JPMorgan Uk Equity Core UCITS ETF (LON:JUKC)
London · Delayed Price · Currency is GBP · Price in GBX 4,129.50
-48.25 (-1.15%)
Last updated: May 28, 2026, 12:04 PM GMT
21.56% (1Y)
| Assets | 414.58M |
| Expense Ratio | 0.25% |
| PE Ratio | 14.32 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +22.14% |
| Volume | 240 |
| Open | 4,153.00 |
| Previous Close | 4,177.75 |
| Day's Range | 4,129.50 - 4,153.00 |
| 52-Week Low | 3,376.95 |
| 52-Week High | 4,280.00 |
| Beta | 0.53 |
| Holdings | 150 |
| Inception Date | Jun 14, 2022 |
About JUKC
JUKC.L was created on 2022-06-14 by JPMorgan. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 410.04m in AUM and 146 holdings. The Sub-Fund aims to achieve a long-term return in excess of the FTSE All-Share Index (Net) (the Benchmark) by actively investing primarily in a portfolio of UK companies.
Asset Class Equity
Category Total Market
Stock Exchange London Stock Exchange
Ticker Symbol JUKC
Provider JPMorgan
Index Tracked FTSE All Share Index - GBP
Performance
JUKC had a total return of 22.14% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.92%.
Top 10 Holdings
43.92% of assets| Name | Symbol | Weight |
|---|---|---|
| HSBC Holdings plc | HSBA | 8.25% |
| AstraZeneca PLC | AZN | 7.45% |
| Shell plc | SHEL | 6.94% |
| Rolls-Royce Holdings plc | RR | 3.69% |
| BP p.l.c. | BP | 3.30% |
| British American Tobacco p.l.c. | BATS | 3.29% |
| GSK plc | GSK | 2.93% |
| Unilever PLC | ULVR | 2.93% |
| Rio Tinto Group | RIO | 2.76% |
| National Grid plc | NG | 2.38% |